This analysis unveiled several promising biomarkers, such as MMP9, PIK3R6, IFNG, and PGF, exhibiting significant associations with overall survival and relapse-free survival in ccRCC patients. This evidence concerns the gene PIK3R6 and nonpapillary renal cell carcinoma.